v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities        
Net income (loss) $ (2,518,084) $ (1,414,618) $ (4,306,918) $ (2,384,802)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock based compensation 682,978 14,261 67,586 275,465
Accrued interest 315,978 138,640    
Gain/loss on settlement of liabilities 565,453 516,083 1,842,273 (441,041)
Fair value of stock issued for note modification 410,008 14,382 449,660 168,856
Amortization of debt discount 24,737 28,497 (28,497)
Changes in operating assets and liabilities:        
Prepaid expenses and other assets 4,073 17,855 39,129 (80,485)
Accounts payable and accrued expenses 183,388 415,506 764,583 165,781
Accrued interest     364,879 46,517
Net cash used in operating activities (356,206) (273,154) (750,311) (2,278,206)
Cash Flows from Investing Activities:        
Acquisition of mineral claims     (106,000)
Net cash provided by (used in) investing activities (106,000)
Cash Flows from Financing Activities        
Proceeds from convertible notes 195,000 25,000 105,000 2,025,000
Proceeds from convertible notes – related party 155,000 80,000 105,000
Repayment of promissory notes     (225,000)
Proceeds from warrant exercises     224,000
Proceeds from promissory notes 179,182 770,831 100,000
Net cash provided by financing activities 350,000 284,182 755,831 2,349,000
Net increase (decrease) in cash (6,206) 11,028 5,520 (35,206)
Cash, beginning of period 12,896 7,376 7,376 42,582
Cash, end of period 6,690 18,404 12,896 7,376
Supplemental disclosures:        
Interest paid
Supplemental disclosures of non-cash items:        
Accounts payable and accrued payable exchanged for convertible note $ 440,129 $ 440,129